Literature DB >> 18600536

Adenosine kinase gene expression in human colorectal cancer.

S Giglioni1, R Leoncini, E Aceto, A Chessa, S Civitelli, A Bernini, G Tanzini, F Carraro, A Pucci, D Vannoni.   

Abstract

Real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to evaluate gene expression of adenosine kinase, a key enzyme in adenosine metabolism, in human intestinal biopsy specimens of 10 colorectal cancer patients. Quantitative mRNA expression levels were normalized against the reference gene beta-actin. The results showed that adenosine kinase gene expression was significantly higher in cancer than in normal-appearing tissue, in line with our previous measurements of adenosine kinase enzyme activities in colorectal tumor samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600536     DOI: 10.1080/15257770802145629

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  12 in total

1.  Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.

Authors:  Utthara Nayar; Jouliana Sadek; Jonathan Reichel; Denise Hernandez-Hopkins; Gunkut Akar; Peter J Barelli; Michelle A Sahai; Hufeng Zhou; Jennifer Totonchy; David Jayabalan; Ruben Niesvizky; Ilaria Guasparri; Duane Hassane; Yifang Liu; Shizuko Sei; Robert H Shoemaker; J David Warren; Olivier Elemento; Kenneth M Kaye; Ethel Cesarman
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

Review 2.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

3.  Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy.

Authors:  Marjolein de Groot; Anand Iyer; Emanuele Zurolo; Jasper Anink; Jan J Heimans; Detlev Boison; Jaap C Reijneveld; Eleonora Aronica
Journal:  Epilepsia       Date:  2011-11-16       Impact factor: 5.864

Review 4.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

5.  The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.

Authors:  Christopher M Cabello; Warner B Bair; Stephanie Ley; Sarah D Lamore; Sara Azimian; Georg T Wondrak
Journal:  Biochem Pharmacol       Date:  2008-12-24       Impact factor: 5.858

Review 6.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

Review 7.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

Review 8.  Adenosine kinase: An epigenetic modulator in development and disease.

Authors:  Madhuvika Murugan; Denise Fedele; David Millner; Enmar Alharfoush; Geetasravya Vegunta; Detlev Boison
Journal:  Neurochem Int       Date:  2021-05-05       Impact factor: 4.297

9.  Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation.

Authors:  Katharina Kiese; Janos Jablonski; Detlev Boison; Katja Kobow
Journal:  Front Mol Neurosci       Date:  2016-10-20       Impact factor: 5.639

10.  Dysregulation of adenosine kinase isoforms in breast cancer.

Authors:  Bahar Shamloo; Nandita Kumar; Randall H Owen; Jesica Reemmer; John Ost; R Serene Perkins; Hai-Ying Shen
Journal:  Oncotarget       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.